Shionogi Files NDA For Rare Lipoatrophy Drug
10:44 EDT 9 Aug 2012 | Elsevier Business Intelligence
Shionogi files NDA in Japan for recombinant Leptin (metreleptin), a lipoatrophy drug that completely or partially eliminates adipose tissue.
Original Article: Shionogi Files NDA For Rare Lipoatrophy Drug
More From BioPortfolio on "Shionogi Files NDA For Rare Lipoatrophy Drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
